Healthcare M&A Industry Update Q4 2024

This report provides an update on the healthcare mergers and acquisitions (M&A) landscape for the fourth quarter of 2024. It outlines key industry trends heading into 2025, including cost pressures and changes in reimbursement models, regulatory scrutiny surrounding private equity deals, and the role of artificial intelligence in enhancing operational efficiency. The report notes that despite ongoing challenges, healthcare M&A activity remained strong with 784 transactions completed in Q4 2024, reflecting sustained momentum. The average deal value increased to $182 million, indicating larger transactions are driving activity. Strategic buyers dominated the market, accounting for 59% of total transaction volume. The report also discusses public market performance, highlighting share price declines across most sectors due to regulatory challenges and labor cost pressures. Overall, optimism for 2025 is supported by a favorable lending environment and anticipated interest rate cuts, which are expected to boost capital investment and deal-making across the healthcare sector.